A Study on the Evaluation of Innovation Performance of Biopharmaceutical Listed Companies:A Perspective of Factor Analysis
Enhancing innovation capability has become a key factor in driving the upgrading of the biopharmaceutical industry.To analyze the innovation performance of listed companies in the biopharmaceutical industry,from the perspectives of innovation input indicators and innovation output indicators.It is constructed an innovation performance evaluation index system tailored to this field.Utilizes factor analysis to empirical-ly analyze data related to biopharmaceutical listed companies in of China from 2017 to 2021.The research results that the innovation perform-ance evaluation index system for biopharmaceutical listed companies should include,namely,innovation input indicators,innovation output indi-cators,and innovation economic benefit indicators.The overall innovation performance of biopharmaceutical listed companies presents a favora-ble trend and exhibits significant regional.Based on these findings,specific recommendations are put forward to optimize the innovation deve-lopment of biopharmaceutical listed companies in China.
NETL
NSTL
万方数据
